Brief: UroGen Pharma Ltd Files For Offering Of Up To 12.6 Million Shares Of Common Stock By The Selling Shareholders - SEC Filing
08/09/2023 21:18
Sept 8 (Reuters) - UroGen Pharma Ltd UR8.F :
* UROGEN PHARMA LTD FILES FOR OFFERING OF UP TO 12.6 MILLION
SHARES OF COMMON STOCK BY THE SELLING SHAREHOLDERS - SEC FILING
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors